ARCHIVES

Chabner Criticizes FDA Crackdown On Off-Label Info

This article is from The Cancer Letter archive.

Vol. 17 No. 26 | June 28, 1991

Download PDF Visit The Full Archive

Related Articles

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

August 30, 2013

DRG Regulation Opponents May Have Powerful New Ally

November 25, 1983

Consensus Panel Determines Total Mastectomy Plus Node Dissection “Satisfactory Alternative” To Radical Mastectomy

June 15, 1979

NCI Advisory Group, Other Cancer Meetings

January 2, 1981

In Brief: NCI Seeking Industry Support Again For Summer Program Congress Oks Smokeless Tobacco Bill

February 14, 1986

DeVita Losing Patience, Responds To Powers Letter

May 6, 1983